The metabolism of APIs can influence their toxicity. Some APIs may be metabolized into toxic metabolites, which can cause adverse effects. The phase I and phase II metabolic pathways are crucial in determining the fate of APIs in the body. Factors such as genetic variations, liver function, and concurrent drug use can affect API metabolism and, consequently, its toxicity.
